⌘K

Login Start Free

Home/Filings/4/0001127602-13-019344

4//SEC Filing

CONMED CORP 4

Accession 0001127602-13-019344

$CNMDCIK 0000816956operating

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:18 PM ET

Size

15.2 KB

Accession

0001127602-13-019344

Insider Transaction Report

Form 4

Period: 2013-06-01

CONMED CORPCNMD

Director

Transactions

Exercise/Conversion
Common Stock
2013-06-01+200→ 2,400 total
Exercise/Conversion
Common Stock
2013-06-01+3,000→ 5,400 total
Exercise/Conversion
Rsus (restricted Stock Units)
2013-06-01−3,000→ 0 total
Exercise: $0.00From: 2013-06-01Exp: 2022-06-01→ Common Stock (3,000 underlying)
Award
Rsus (restricted Stock Units)
2013-06-01+3,000→ 3,000 total
Exercise: $0.00From: 2014-06-01Exp: 2023-06-01→ Common Stock (3,000 underlying)
Exercise/Conversion
Rsus (restricted Stock Units)
2013-06-01−200→ 200 total
Exercise: $0.00Exp: 2019-06-01→ Common Stock (200 underlying)
Award
Sars (Stock Appreciation Rights)
2013-06-01+1,000→ 1,000 total
Exercise: $32.93From: 2014-06-01Exp: 2023-06-01→ Common Stock (1,000 underlying)

Footnotes (3)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 20% per year over a five year period, with any unvested RSUs to vest and be delivered upon the Director's termination of service provided the Director has completed one full year of service since the date of the award.
[F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
[F3]The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CONMED CORP

CIK 0000816956

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000816956

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 4:18 PM ET
Size: 15.2 KB

View on SEC.gov